Nephros, Inc.

NasdaqCM:NEPH Stock Report

Market Cap: US$45.7m

Nephros Management

Management criteria checks 3/4

Nephros' CEO is Robert Banks, appointed in May 2023, has a tenure of 3.25 years. total yearly compensation is $627.13K, comprised of 57.8% salary and 42.2% bonuses, including company stock and options. directly owns 1.75% of the company’s shares, worth $799.90K. The average tenure of the management team and the board of directors is 3.6 years and 3.9 years respectively.

Key information

Robert Banks

Chief executive officer

US$627.1k

Total compensation

CEO salary percentage57.80%
CEO tenure3.3yrs
CEO ownership1.8%
Management average tenure3.6yrs
Board average tenure3.9yrs

Recent management updates

Recent updates

Narrative Update Aug 01

NEPH: Index Additions And Water Filtration Leadership Will Support Future Upside

Analysts trimmed their fair value estimate for Nephros from $7 to $6, citing a higher future P/E assumption of about 50x and a weaker profit margin outlook. They also highlight the company's five nanometer ultrafilter and indicate they would like to see revenue growth trends improve further before becoming more positive on the stock.
Narrative Update Jul 17

NEPH: Index Additions And Mergers Will Shape Future Trading Profile

Analysts now see Nephros shares fairly valued closer to $4.00 per share, aligning with a new $4 price target that reflects confidence in its ultrafilter technology, while also recognizing that recent gains already capture much of the anticipated growth until revenue expansion re-accelerates above 20%. What’s in the News for Nephros Nephros is actively seeking acquisitions, merger partners, and business development investments, with management indicating an interest in opportunities that they view as offering a significantly higher return on investment, source: Nephros investor event.
Analysis Article May 11

Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Lifting Their Price Targets

It's been a pretty great week for Nephros, Inc. ( NASDAQ:NEPH ) shareholders, with its shares surging 15% to US$3.52 in...
Analysis Article Apr 29

Is Nephros, Inc. (NASDAQ:NEPH) Potentially Undervalued?

Nephros, Inc. ( NASDAQ:NEPH ), might not be a large cap stock, but it saw a decent share price growth of 19% on the...
Analysis Article Feb 06

Nephros, Inc.'s (NASDAQ:NEPH) Popularity With Investors Under Threat As Stock Sinks 28%

Nephros, Inc. ( NASDAQ:NEPH ) shareholders won't be pleased to see that the share price has had a very rough month...
Analysis Article Jan 07

Is It Time To Consider Buying Nephros, Inc. (NASDAQ:NEPH)?

Nephros, Inc. ( NASDAQ:NEPH ), is not the largest company out there, but it received a lot of attention from a...
Analysis Article Dec 13

Nephros (NASDAQ:NEPH) Is Experiencing Growth In Returns On Capital

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...
Analysis Article Oct 01

Why Investors Shouldn't Be Surprised By Nephros, Inc.'s (NASDAQ:NEPH) 27% Share Price Surge

Nephros, Inc. ( NASDAQ:NEPH ) shareholders would be excited to see that the share price has had a great month, posting...
Analysis Article Sep 13

At US$4.26, Is Nephros, Inc. (NASDAQ:NEPH) Worth Looking At Closely?

Nephros, Inc. ( NASDAQ:NEPH ), is not the largest company out there, but it saw a significant share price rise of 47...
Analysis Article Aug 07

It's Down 26% But Nephros, Inc. (NASDAQ:NEPH) Could Be Riskier Than It Looks

NasdaqCM:NEPH 1 Year Share Price vs Fair Value Explore Nephros's Fair Values from the Community and select yours...
Analysis Article Jun 16

Nephros, Inc.'s (NASDAQ:NEPH) 79% Jump Shows Its Popularity With Investors

Despite an already strong run, Nephros, Inc. ( NASDAQ:NEPH ) shares have been powering on, with a gain of 79% in the...
Analysis Article May 14

Should You Think About Buying Nephros, Inc. (NASDAQ:NEPH) Now?

Nephros, Inc. ( NASDAQ:NEPH ), is not the largest company out there, but it led the NASDAQCM gainers with a relatively...
Analysis Article Apr 18

Investors Still Aren't Entirely Convinced By Nephros, Inc.'s (NASDAQ:NEPH) Revenues Despite 32% Price Jump

Nephros, Inc. ( NASDAQ:NEPH ) shares have had a really impressive month, gaining 32% after a shaky period beforehand...
Analysis Article Oct 03

It's A Story Of Risk Vs Reward With Nephros, Inc. (NASDAQ:NEPH)

There wouldn't be many who think Nephros, Inc.'s ( NASDAQ:NEPH ) price-to-sales (or "P/S") ratio of 1.2x is worth a...
Analysis Article Jul 14

We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn

We can readily understand why investors are attracted to unprofitable companies. For example, although...
Analysis Article May 13

Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates

Shareholders might have noticed that Nephros, Inc. ( NASDAQ:NEPH ) filed its quarterly result this time last week. The...
Analysis Article Dec 18

After Leaping 40% Nephros, Inc. (NASDAQ:NEPH) Shares Are Not Flying Under The Radar

Nephros, Inc. ( NASDAQ:NEPH ) shares have continued their recent momentum with a 40% gain in the last month alone. The...
Analysis Article Dec 14

At US$3.18, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?

Nephros, Inc. ( NASDAQ:NEPH ), might not be a large cap stock, but it received a lot of attention from a substantial...

CEO Compensation Analysis

How has Robert Banks's remuneration changed compared to Nephros's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2026n/an/a

US$2m

Mar 31 2026n/an/a

US$776k

Dec 31 2025US$627kUS$363k

US$1m

Sep 30 2025n/an/a

US$1m

Jun 30 2025n/an/a

US$1m

Mar 31 2025n/an/a

US$801k

Dec 31 2024US$410kUS$350k

US$74k

Sep 30 2024n/an/a

-US$929k

Jun 30 2024n/an/a

-US$1m

Mar 31 2024n/an/a

-US$1m

Dec 31 2023US$824kUS$229k

-US$2m

Compensation vs Market: Robert's total compensation ($USD627.13K) is about average for companies of similar size in the US market ($USD655.04K).

Compensation vs Earnings: Robert's compensation has increased by more than 20% in the past year.


CEO

Robert Banks (51 yo)

3.3yrs
Tenure
US$627,125
Compensation

Mr. Robert Banks is President, Director & CEO of Nephros, Inc. from May 2023. Mr. Banks has a proven track record of delivering value through innovation and aligning the strengths of his organizations with...


Leadership Team

NamePositionTenureCompensationOwnership
Robert Banks
President3.3yrsUS$627.13k1.75%
$ 799.9k
Judy Krandel
Chief Financial Officer2.8yrsUS$322.62k0.63%
$ 289.9k
Brianne McGuire
Director of Brand3.6yrsno datano data
Vashone Thomas
Vice President of Quality4.6yrsno datano data
Greg Lucas
President of Aether Water Systems5.8yrsno datano data
Judy Mazzini
Controller3.6yrsno datano data
Michael Milman
Vice President of R&D9.5yrsno datano data
3.6yrs
Average Tenure

Experienced Management: NEPH's management team is considered experienced (3.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Robert Banks
President3.3yrsUS$627.13k1.75%
$ 799.9k
Arthur Amron
Director18.9yrsUS$33.67k1.28%
$ 582.9k
Oliver Spandow
Independent Director8yrsUS$44.22k1.13%
$ 517.3k
Joseph Harris
Independent Director3.9yrsUS$23.00k0.16%
$ 74.5k
Lisa Nettis
Director1.2yrsUS$49.00k0.015%
$ 6.8k
3.9yrs
Average Tenure
55yo
Average Age

Experienced Board: NEPH's board of directors are considered experienced (3.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/10 13:47
End of Day Share Price 2026/08/10 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nephros, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert WassermanBenchmark Company
Marc WiesenbergerB. Riley Securities, Inc.
Anthony VendettiMaxim Group